Louis St. Laurence O'Dea
Geen lopende functies
Profiel
Louis St. Laurence O'Dea held several positions in the medical industry, including Chief Medical Officer and Senior Vice President at Radius Health, Vice President of Clinical Development at Serono Corp, Chief Medical Officer at Oxford Immunotec Global Ltd, Chief Medical Officer at Akcea Therapeutics, and Chief Medical Officer and Head of Regulatory Affairs at Moderna, Inc. He received his undergraduate and doctorate degrees from University College Dublin.
Eerdere bekende functies van Louis St. Laurence O'Dea
Bedrijven | Functie | Einde |
---|---|---|
AKCEA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 07-07-2020 |
OXFORD IMMUNOTEC GLOBAL PLC | Hoofd Techniek/Wetenschap/O&O | 01-01-2016 |
MODERNA, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2014 |
RADIUS HEALTH, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Serono Corp. | Corporate Officer/Principal | 01-01-2006 |
Opleiding van Louis St. Laurence O'Dea
University College Dublin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MODERNA, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Serono Corp. | |
Oxford Immunotec Global Ltd.
Oxford Immunotec Global Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Global Ltd. operates as a diagnostics company, which develops and commercializes proprietary tests for immunology and infectious disease. Its products include T-SPOT.TB, T-SPOT.CMV, T-SPOT.PRT and T-CELL XTEND. The company was founded by Peter James Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Akcea Therapeutics, Inc.
Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |